Full-Time

Senior Associate Quality Assurance

Global Supply Quality

Confirmed live in the last 24 hours

Amgen

Amgen

10,001+ employees

Develops biologic therapies for serious illnesses

No salary listed

Senior

Hyderabad, Telangana, India

In Person

Category
QA & Testing
Quality Assurance
Required Skills
Risk Management
Requirements
  • Master’s degree and 1 to 3 years of professional experience in related fields OR
  • Bachelor’s degree and 3 to 5 years of professional experience in related fields OR
  • Diploma and 7 to 9 years of professional experience in related fields
  • Understanding of GMP/GDP requirements.
  • Familiarity with raw material compendial testing
  • Experience overseeing quality of suppliers or external parties
  • Strong technical writing skills
Responsibilities
  • Perform QA Contact role on the Quality Events, Change Control records, Corrective and Preventive Actions, effectiveness verification and documentation
  • Work closely with all relevant stakeholders for the end-to-end process and ensure compliance to GMP/GDP.
  • Prepare, review and approve SOPs and other GMP/GDP documentation in compliance with corporate and regulatory requirements, to ensure alignment with procedures, current Good Manufacturing Practices (cGMP), Good Distribution Practices (GDP) and other applicable regulations
  • Collaborate with raw material suppliers to ensure adherence to quality agreements, identifying performance improvement opportunities
  • Understand and incorporate risk management strategy into the overall raw material lifecycle
  • Provide support to the supplier periodic monitoring oversight activities
  • Support in tactical activities related to internal/external audits and inspections
  • Perform routine quality assessments and provide approval of changes to raw material inspection profiles
  • Take part in operational improvement initiatives, programs, and projects
  • Develop solutions that are thorough, practical, and consistent with functional objectives
  • Ownership of supplier metrics, performance assessments, and other key documents to inform the health of supplier relationships.
  • Work under minimal supervision in line with Amgen Values and Leadership Attributes.
  • This role may require working in shifts or extended hours within the same shift to support global timezones.
Desired Qualifications
  • Experience and strong familiarity with digital tools and computerized systems.
  • Strong continuous improvement approach and lean practices experience.
  • Understanding of end-to-end supply chain business processes.
  • Experience in project management across multiple departments and geographies.
  • Quick process understanding, insight and visualizing.
  • Strong analytical and problem-solving skills.
  • Independent self-starter, able to work autonomously, under pressure and in teams.
  • GMP/GDP knowledge and understanding of pharmaceutical regulations.
  • Energetic, detail oriented, highly motivated with a “can do” outlook.
  • Change management skills.
  • Ability to communicate across all levels of the organization.
  • Effective written and verbal communication skills.
  • Experience with Microsoft Office Tools including Excel, Word, and PowerPoint.
  • Ability to multi-task and prioritize

Amgen develops medicines aimed at treating serious illnesses, focusing on biotechnology. The company researches, develops, and sells biologic therapies, which are derived from living organisms, to address conditions like cancer, cardiovascular diseases, and autoimmune disorders. Amgen's products work by utilizing biological processes to create effective treatments for patients. Unlike many competitors, Amgen emphasizes a strong commitment to research and development, reinvesting a large portion of its earnings to discover new therapies. The company's goal is to improve patient care and outcomes by providing effective therapeutic solutions.

Company Size

10,001+

Company Stage

IPO

Headquarters

Thousand Oaks, California

Founded

1980

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of Micromet boosts Amgen's oncology portfolio with BiTE antibody blinatumomab.
  • Institutional investments indicate strong confidence in Amgen's financial health and prospects.
  • Amgen's AI-driven drug discovery investments could accelerate R&D capabilities.

What critics are saying

  • Micromet acquisition may face clinical or regulatory challenges impacting strategic goals.
  • Investor pressure for short-term gains may affect long-term R&D investments.
  • FTC scrutiny on mergers could hinder Amgen's future strategic growth.

What makes Amgen unique

  • Amgen focuses on biologic therapies derived from living organisms.
  • The company has a strong pipeline in oncology, cardiovascular, and autoimmune disorders.
  • Amgen's strategic acquisitions enhance its innovative medicine portfolio.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Professional Development Budget

Conference Attendance Budget

Company News

Amgen
Jun 2nd, 2025
Amgen to Acquire Micromet| Amgen

The acquisition includes blinatumomab, a Bispecific T cell Engager (BiTE) antibody in Phase 2 clinical development for acute lymphoblastic leukemia (ALL). Blinatumomab is also in clinical development for the treatment of non-Hodgkin's lymphoma (NHL), and could have applications in other hematologic malignancies.

MarketBeat
Jan 28th, 2024
Factory Mutual Insurance Co. Makes New Investment in Amgen Inc. (NASDAQ:AMGN)

Factory Mutual Insurance Co. purchased a new position in Amgen Inc. (NASDAQ:AMGN - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 53,500 shares of the medical research company's stock, valued at approxim

The Quantum Insider
Jan 16th, 2024
Honeywell Announces the Closing of $300 Million Equity Investment Round for Quantinuum at $5 Billion Pre-Money Valuation

JPMorgan Chase has one of the world's most highly regarded specialist teams working on quantum technologies within the financial services industry and has been working with Quantinuum and its predecessor companies since 2020.

ETF Daily News
Dec 17th, 2023
Northwest Quadrant Wealth Management LLC Invests $237,000 in Amgen Inc. (NASDAQ:AMGN)

Northwest Quadrant Wealth Management LLC bought a new position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund bought 883 shares of the medical research company’s stock, valued at approximately $237,000. A number of other institutional investors […]

Horizon Therapeutics
Sep 21st, 2023
Rule 2.7 Announcement: Amgen Inc to Acquire Horizon Therapeutics plc | Horizon Therapeutics plc

The Investor Relations website contains information about Horizon Therapeutics plc's business for stockholders, potential investors, and financial analysts.